Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-076-7 | CAS number: 51-03-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- short-term repeated dose toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1992
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 82-2 (Repeated Dose Dermal Toxicity -21/28 Days)
- GLP compliance:
- yes
- Limit test:
- yes
Test material
- Reference substance name:
- 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
- EC Number:
- 200-076-7
- EC Name:
- 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
- Cas Number:
- 51-03-6
- Molecular formula:
- C19H30O5
- IUPAC Name:
- 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
Constituent 1
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Hazleton Research Products Inc., Kalamazoo, Michigan.
- Age at study initiation: 3 months
- Weight at study initiation: 2.03-2.86 kg (males); 2.09-2.89 kg (females)
- Number of animals per group: 5 males and 5 females per group
- Control animals: Yes (5 males and 5 females)
- Housing: the rabbits were individually hooused in a stainless steel cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 17 days
ENVIRONMENTAL CONDITIONS
- Temperature: 20 ± 1 °C
- Humidity: 72 ± 4%
- Air changes (per hr):
- Photoperiod: 12-hrs light / 12-hrs dark
IN-LIFE DATES: From: 10 June 1991 (receipt date) To: 18-19 July 1991 (sacrifice date)
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TEST SITE
- Area of exposure: approximately 15 cm wide
- % coverage: 75% group 1 (control group); 5% group 2; 15% group 3; 65% group 4.
- Type of wrap if used: The test site were wrapped with gauze bandaging and secured with non irritating tape.
- Time intervals for shavings or clipplings: The hair was clipped as necessary during the study period to prevent the test article from becoming matted in the hair and to facilitate accurate observations.
REMOVAL OF TEST SUBSTANCE
- Washing: The test site was wiped with disposable toweling
- Time after start of exposure: approximately 6 hours
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): The test article was administered at dosage levels of 0 (control), 100, 300 and 1000 mg/kg (in terms of actual PBO content) using an appropriate size syringe
USE OF RESTRAINERS FOR PREVENTING INGESTION: no. The test substance was applied on the back of the animal and each animal was housed individually in a stainless steel cage. - Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 21 days
- Frequency of treatment:
- 5 days per week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0 (control), 100, 300, 1000 mg/kg bw/d
Basis:
nominal per unit body weight
- No. of animals per sex per dose:
- 5/male/0; 5/male/100; 5/male/300; 5/male/1000 mg/kg bw/d.
5/female/0; 5/female/100; 5/female/300; 5/female/1000 mg/kg bw/d. - Control animals:
- yes
- Details on study design:
- - Route of exposition selection rationale: A potential route of exposure to humans is dermal. Therefore, this route of administration was employed in this study.
- Dose selection rationale: The doses chosen cover three different situations of dermal exposition: low, medium and high
Examinations
- Observations and examinations performed and frequency:
- - CLINICAL SIGNS, MORTALITY
Observations were conducted twice daily to assess mortality, morbidity and signs of overt toxicity. A more detailed physical examination was conducted on each animal on a weekly basis. Individual body weight and food consumption were measured weekly.
BODY WEIGHT
Individual body weights were measured weekly.
FOOD CONSUMPTION
Individual food consumption was measured weekly.
WATER CONSUMPTION
Not recorded
OPHTHALMOSCOPIC EXAMINATION
No
HAEMATOLOGY
Clinical laboratory studies were conducted at pre-initiation and termination.
Blood samples were collected from the central ear artery following an overnight fasting period in which animals had free access to water. Hematological parameters examined were leukocyte and erythrocyte count, hemoglobin, hematokrit, MCV, MCH, MCMC, platelets and differential leukocyte count. Clinical parameters measured were sodium, potassium, chloride, calcium, phosphorous, alkaline phosphatase, bilirubin, AST, ALT, urea nitrogen, creatinine, protein, albumin, globulin, cholesterol and glucose.
CLINICAL CHEMISTY
Clinical laboratory studies were conducted at pre-initiation and termination.
Clinical parameters measured were sodium, potassium, chloride, calcium, phosphorous, alkaline phosphatase, bilirubin, AST, ALT, urea nitrogen, creatinine, protein, albumin, globulin, cholesterol and glucose.
URINALYSIS
Not performed. - Sacrifice and pathology:
- ORGAN WEIGHTS, GROSS AND HISTOPATHOLOGY
All survivors were euthanized by intravenous sodium pentobarbital followed by exsanguinations.. All animals received a complete postmortem examination under the direct supervision of a pathologist. At necropsy, the adrenals, kidneys, liver and testis were weighed. Microscopic examination of sections preserved in formalin fixed hematoxylin-eosin stained paraffin were performed on all animals. Macroscopic lesions in any other tissue were also examined. - Statistics:
- Body weights, food consumption, haematological and biochemical parameters and absolute and relative organ weights were analyzed using analysis of variance (one way classification) and Bartelett’s test for homogeneity of variance. Treatment groups were compared to the control group by sex using the appropriate t-statistic. For determination of significance of differences, Dunnett’s multiple comparison tables or pair wise comparison with a Bonferroni correction were used. All statistical tests are two-tailed, with p ≤ 0.05 and p ≤ 0.01 used as levels of significance.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No remarkable findings were noted
- Dermal irritation:
- effects observed, treatment-related
- Description (incidence and severity):
- See "Details on results"
- Mortality:
- no mortality observed
- Description (incidence):
- No remarkable findings were noted
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Urinalysis findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- See "Details on results"
- Details on results:
- CLINICAL SIGNS AND MORTALITY
All test animals survived until termination of the study.
DERMAL IRRITATION
Treatment related effects were limited to minor changes in the skin at the application site.Dermal irritation was observed in all three groups, altough a lesser extent and incidence at 100 mg/kg level.
Very slight erythema and edema appeared by day 5 and generally persisted. At 300 and 1000 mg/kg noted desquamation and fissuring.
At necropsy, findings in the treated animals included red, disclored areas, scabs and thickening of the skin. Microscopic evaluation of the application site skin revealed trace to moderate acanthosis, hyperkeratosis and chronic inflammation of the epidermis. The severity of these lesions increased with increasing dose in both sexes. Acanthosis and chronic inflammation were also noted in the control group, although at a lower incidence and all of the lesions were graded as trace or mild.
BODY WEIGHT AND WEIGHT GAIN
There were no remarkable changes or differences observed in body weights during the study period (see the table reported in "Any other information on results incl. tables")
FOOD CONSUMPTION
Although food consumption was generally lower in treated animals there was no statistically significant difference between controls and treated groups.
WATER CONSUMPTION
No data
OPHTHALMOSCOPIC EXAMINATION
Not done
HAEMATOLOGY
No effects
CLINICAL CHEMISTRY
No effects.
URINALYSIS
Not done
ORGAN WEIGHTS
There were no significant differences in absolute and relative organ weights for either sex among the treatment groups.
GROSS PATHOLOGY AND HISTOPATHOLOGY
No effects
Effect levels
open allclose all
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- >= 1 000 mg/kg bw/day
- Sex:
- male/female
- Basis for effect level:
- other: does not cause systemic toxicity to the rabbit at a 3 week repeated dermal application of 1000 mg/kg b.w.
- Key result
- Dose descriptor:
- LOAEL
- Effect level:
- >= 1 000 mg/kg bw/day
- Sex:
- male/female
- Basis for effect level:
- other: does not cause systemic toxicity to the rabbit at a 3 week repeated dermal application of 1000 mg/kg b.w.
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The table reported below has been extracted from the full study report N. 542 -007
Dodsage Level(mg/kg) |
|
Mean Body Weigth, grams (percent difference from control) |
|
Males |
Females |
||
0 (Control) |
2780 |
2761 |
|
100 |
2691 (- 3,2) |
2640 (- 4,4) |
|
300 |
2825(+ 1,6) |
2868 (+ 3,9) |
|
1000 |
2777 (- 0,1) |
2790 (+ 1,1) |
Applicant's summary and conclusion
- Conclusions:
- MATERIALS AND METHODS
A repeated dose dermal toxicity study according to US EPA Pesticide Assessment Guidelines, Subdivision F, 82-2.
Piperonyl butoxide was administered dermally, undiluted as received, at dosage levels of 100, 300 and 1000 mg/kg b.w. once daily, five days per week for three weeks to five rabbits per sex and dosage group. A control group received mineral oil at the same treatment regime.
Observations were conducted to assess mortality, morbidity and signs of ouvert toxicity. Clinical signs, body weight and food consumption were recorded. In addition haematology and clinical biochemistry, gross pathology and histopathology were investigated.
RESULTS AND DISCUSSION
Treatment related effects were limited to minor changes in the skin at the application site.
CONCLUSION
The dermal administration of the substance up to 1000 mg/kg for 21 days caused no systemic toxicity in male and female rabbits. Topical administration did produce a range of macroscopically and microscopically observed dermal irritation consisting of changes in the epithelium which were dose related in incidence and degree.
Finally, it is concluded that Piperonyl Butoxide does not cause systemic toxicity to the rabbit at a 3 week repeated dermal application of 1000 mg/kg b.w.
LO(A)EL > 1000 mg/kg b.w.
NO(A)EL = 1000 mg/kg b.w.
Reliability: 1
Deficiencies: No
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.